Sobel BE - Search Results

1

Hemostatic changes and clinical sequelae after on-pump compared with off-pump coronary artery bypass surgery: a prospective randomized study.

Paulitsch FS, Schneider D, Sobel BE, Rached R, Ramires J, Jatene F, Stolf N, Hueb W, Lopes NH. Paulitsch FS, et al. Among authors: sobel be. Coron Artery Dis. 2009 Mar;20(2):100-5. doi: 10.1097/MCA.0b013e3283219e8b. Coron Artery Dis. 2009. PMID: 19293667 Clinical Trial.

2

Soluble CD40 ligand is an early initiator of inflammation after coronary intervention.

Aggarwal A, Blum A, Schneider DJ, Sobel BE, Dauerman HL. Aggarwal A, et al. Among authors: sobel be. Coron Artery Dis. 2004 Dec;15(8):471-5. doi: 10.1097/00019501-200412000-00003. Coron Artery Dis. 2004. PMID: 15585987 Clinical Trial.

3

Streamlining the design of promising clinical trials: in-vitro testing of antithrombotic regimens and multiple agonists of platelet activation.

Schneider DJ, Sobel BE. Schneider DJ, et al. Among authors: sobel be. Coron Artery Dis. 2009 Mar;20(2):175-8. doi: 10.1097/MCA.0b013e32831edcd1. Coron Artery Dis. 2009. PMID: 19194284

4

Synergistic augmentation of expression of plasminogen activator inhibitor type-1 induced by insulin, very-low-density lipoproteins, and fatty acids.

Schneider DJ, Sobel BE. Schneider DJ, et al. Among authors: sobel be. Coron Artery Dis. 1996 Nov;7(11):813-7. doi: 10.1097/00019501-199611000-00004. Coron Artery Dis. 1996. PMID: 8993938

5

The effects of bivalirudin compared with those of unfractionated heparin plus eptifibatide on inflammation and thrombin generation and activity during coronary intervention.

Keating FK, Dauerman HL, Whitaker DA, Sobel BE, Schneider DJ. Keating FK, et al. Among authors: sobel be. Coron Artery Dis. 2005 Sep;16(6):401-5. doi: 10.1097/00019501-200509000-00010. Coron Artery Dis. 2005. PMID: 16118546 Clinical Trial.

6

Efficiency in clinical research: assessment in vitro of potential anti-thrombotic drug interactions.

Schneider DJ, Whitaker DA, Sobel BE. Schneider DJ, et al. Among authors: sobel be. Coron Artery Dis. 2004 May;15(3):177-81. doi: 10.1097/00019501-200405000-00007. Coron Artery Dis. 2004. PMID: 15096999

7

Greater inhibitory effects of bivalirudin compared with unfractionated heparin plus eptifibitide on thrombin-induced platelet activation.

Schneider DJ, Keating F, Sobel BE. Schneider DJ, et al. Among authors: sobel be. Coron Artery Dis. 2006 Aug;17(5):471-6. doi: 10.1097/00019501-200608000-00011. Coron Artery Dis. 2006. PMID: 16845256

8

Platelet function, coagulopathy, and impaired fibrinolysis in diabetes.

Sobel BE, Schneider DJ. Sobel BE, et al. Cardiol Clin. 2004 Nov;22(4):511-26. doi: 10.1016/j.ccl.2004.06.009. Cardiol Clin. 2004. PMID: 15501620 Review.

9

A randomized trial of therapies for type 2 diabetes and coronary artery disease.

BARI 2D Study Group; Frye RL, August P, Brooks MM, Hardison RM, Kelsey SF, MacGregor JM, Orchard TJ, Chaitman BR, Genuth SM, Goldberg SH, Hlatky MA, Jones TL, Molitch ME, Nesto RW, Sako EY, Sobel BE. BARI 2D Study Group, et al. Among authors: sobel be. N Engl J Med. 2009 Jun 11;360(24):2503-15. doi: 10.1056/NEJMoa0805796. Epub 2009 Jun 7. N Engl J Med. 2009. PMID: 19502645 Free PMC article. Clinical Trial.

10

PAI-1 and diabetes: a journey from the bench to the bedside.

Schneider DJ, Sobel BE. Schneider DJ, et al. Among authors: sobel be. Diabetes Care. 2012 Oct;35(10):1961-7. doi: 10.2337/dc12-0638. Diabetes Care. 2012. PMID: 22996180 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

698 results

Search Page

Filters